Japanese telecommunications giant NTT DOCOMO, in partnership with startup PaMeLa, has unveiled a groundbreaking technology designed to measure and reproduce individual perceptions of pain, marking a major milestone in the intersection of neuroscience and healthcare innovation.
The system uses EEG (electroencephalography) sensors combined with artificial intelligence to analyze the neural signals produced when a person experiences pain. Based on those unique patterns, the technology can recreate the same sensation in another individual, offering a new way to understand human suffering from a scientific and medical perspective.
Researchers say the innovation could have profound therapeutic applications, particularly for patients with chronic pain disorders or in medical training programs, allowing healthcare professionals to better grasp what their patients actually feel. “Pain is a subjective experience—each person feels it differently. Our goal is to translate that experience into a language that can be shared and scientifically studied,” explained PaMeLa’s lead researchers.
Still in its experimental phase, the project is being closely monitored by bioethics and neurosecurity committees, as the ability to “transmit sensations” between people raises important ethical questions about emotional privacy and informed consent.
Early clinical trials, however, have shown promising results, with the system able to replicate mild to moderate sensations with high precision and no adverse effects. If validated in future studies, Japan could become the first nation to certify neurosensory communication technology for pain, transforming how medicine, science, and empathy intersect through innovation.
